Weight-loss drug crackdown
This article was originally published in The Tan Sheet
FDA adds 13 products to a list of weight-loss supplements found to be contaminated with prescription drugs or chemicals, most of which appear to be manufactured in China, FDA reports in a question-and-answer notice. The Center for Drug Evaluation and Research reported Dec. 22 that it may file criminal charges against the manufacturers of 28 products it initially found to have undeclared pharmaceutical drugs in the ongoing investigaton (1"The Tan Sheet" Jan. 5, 2009, p. 8). CDER is declining to identify the manufacturers
You may also be interested in...
FDA's enforcement action against 28 weight-loss products found to contain undeclared pharmaceutical ingredients drew applause from GlaxoSmithKline, marketer of alli, the only OTC drug approved for weight loss in the U.S
Akcea Therapeutics has lowered its asking price in England for its antisense therapy for familial chylomicronaemia syndrome. It has also struck a pricing and reimbursement deal for the drug in Germany.
Fresenius Kabi must pay Eli Lilly €28m in damages after a French court of first instance found that the generics firm’s pemetrexed infringed intellectual property protecting the Alimta chemotherapy brand. The German firm has commented on possible next steps.